Trial Profile
An open-labeled, randomized, single-dose, 2-period, 2-treatment, 2-way crossover bioequivalence study of Valsartan/Amlodipine 160/10 mg in male and female subjects under fasting conditions.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Acronyms PRT-008-15
- 05 Jun 2017 New trial record